Algorithmes d’identification des rhumatismes inflammatoires chroniques et du psoriasis dans les bases médico-administratives : revue de la littérature

Revue d'Épidémiologie et de Santé Publique - Tập 69 - Trang 225-233 - 2021
B. Castagné1,2, M. Viprey3,2, P. Caillet-Pascal4, M. Belhassen2,5, G. Desjeux6, S. Bailly7,8, C. Estellat9, M. Soubrier10, A.M. Schott3,2
1Internal medicine unit, CH Émile-Roux, 43000 Le-Puy-en-Velay, France
2Health services and performance research (HESPER), université Claude-Bernard Lyon 1, 69000 Lyon, France
3Medical information, epidemiology, research division, hospices civils de Lyon, 69000 Lyon, France
4Clinical pharmacology unit, addictovigilance center, CHU de Nantes, Nantes, France
5PELyon, 69000 Lyon, France
6Sanoïa, E-health services, 13420 Gémenos, France
7HP2 laboratory, Inserm U1042, université Grenoble Alpes, 38000 Grenoble, France
8EFCR laboratory, université Grenoble Alpes, 38000 Grenoble, France
9Pharmaco-epidemiology center/clinical research unit, biostatistics department, public health and medical information, Inserm UMR 1123 ECEVE/CIC 1421, hôpitaux universitaires Pitié-Salpêtrière–Charles-Foix, 75013 Paris, France
10Rhumatology unit, CHU Gabriel-Montpied, 63000 Clermont-Ferrand, France

Tài liệu tham khảo

Guillemin, 2005, Prevalence of rheumatoid arthritis in France: 2001, Ann Rheum Dis, 64, 1427, 10.1136/ard.2004.029199 Haroon, 2014, Increasing proportion of female patients with ankylosing spondylitis: a population-based study of trends in the incidence and prevalence of AS, BMJ Open, 4, e006634, 10.1136/bmjopen-2014-006634 Parisi, 2013, Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence, J Invest Dermatol, 133, 377, 10.1038/jid.2012.339 Pharmacoepidemiology, 6th Edition | Wiley [Internet]. Wiley.com. [cité 13 déc 2020. Disponible sur : https://www.wiley.com/en-us/Pharmacoepidemiology%2C+6th+Edition-p-9781119413417]. Tuppin, 2017, Value of a national administrative database to guide public decisions: from the système national d’information inter-régimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France, Rev Epidemiol Sante Publique, 65, S149, 10.1016/j.respe.2017.05.004 Goldberg, 2017, [The REDSIAM network], Rev Epidemiol Sante Publique, 65, S144, 10.1016/j.respe.2017.06.001 Caillet, 2017, [Algorithms for the identification of hospital stays due to osteoporotic femoral neck fractures in European medical administrative databases using ICD-10 codes: a non-systematic review of the literature], Rev Epidemiol Sante Publique, 65, S198, 10.1016/j.respe.2017.04.058 Quantin, 2017, [Study of algorithms to identify schizophrenia in the SNIIRAM database conducted by the REDSIAM network], Rev Epidemiol Sante Publique, 65, S226, 10.1016/j.respe.2017.03.133 Bousquet, 2017, [Using cancer case identification algorithms in medico-administrative databases: Literature review and first results from the REDSIAM Tumors group based on breast, colon, and lung cancer], Rev Epidemiol Sante Publique, 65, S236, 10.1016/j.respe.2017.04.057 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, 339, b2535, 10.1136/bmj.b2535 Fautrel, 2005, Impact of medical practices on the costs of management of rheumatoid arthritis by anti-TNFalpha biological therapy in France, Joint Bone Spine, 72, 550, 10.1016/j.jbspin.2004.12.009 Maravic, 2010, Economic impact of rheumatoid arthritis (RA) biotherapies in France, Joint Bone Spine, 77, 319, 10.1016/j.jbspin.2010.04.001 Fautrel, 2016, Healthcare service utilisation costs attributable to rheumatoid arthritis in France: analysis of a representative national claims database, Joint Bone Spine, 83, 53, 10.1016/j.jbspin.2015.02.023 ameli.fr – Dispositif des ALD [Internet]. [cité 15 déc 2020. Disponible sur : https://www.ameli.fr/l-assurance-maladie/statistiques-et-publications/donnees-statistiques/affection-de-longue-duree-ald/dispositif-des-ald.php]. Hyldgaard, 2017, A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality, Ann Rheum Dis, 10.1136/annrheumdis-2017-211138 Peschken, 2016, A population-based study of intensive care unit admissions in rheumatoid arthritis, J Rheumatol, 43, 26, 10.3899/jrheum.150312 Otsa, 2013, The prevalence of rheumatoid arthritis in Estonia: an estimate based on rheumatology patients’ database, Rheumatol Int, 33, 955, 10.1007/s00296-012-2473-6 Mantel, 2017, Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis, Ann Rheum Dis, 76, 2017, 10.1136/annrheumdis-2017-211608 Sakai, 2016, High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database, Modern Rheumatol, 26, 522, 10.3109/14397595.2015.1106682 Eriksson, 2017, Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?, Ann Rheum Dis, 76, 364, 10.1136/annrheumdis-2016-209315 Zou, 2017, Risk of cardiovascular disease in Chinese patients with rheumatoid arthritis: a cross-sectional study based on hospital medical records in 10 years, PLoS ONE, 12, e0180376, 10.1371/journal.pone.0180376 Khan, 2013, Cardiovascular morbidity in rheumatoid arthritis patients in North Canterbury, New Zealand 1999–2008, Int J Rheum Dis, 16, 19, 10.1111/1756-185x.12008 Exarchou, 2016, Mortality in ankylosing spondylitis: results from a nationwide population-based study, Ann Rheum Dis, 75, 1466, 10.1136/annrheumdis-2015-207688 Śliwczyński, 2015, Prevalence of ankylosing spondylitis in Poland and costs generated by AS patients in the public healthcare system, Rheumatol Int, 35, 1361, 10.1007/s00296-015-3247-8 Kristensen, 2015, Safety of etoricoxib, celecoxib, and nonselective nonsteroidal anti-inflammatory drugs in ankylosing spondylitis and other spondyloarthritis patients: a Swedish National Population-Based Cohort Study: spondyloarthritis and safety of COX inhibitors, Arthritis Care Res, 67, 1137, 10.1002/acr.22555 Muñoz-Ortego, 2014, Ankylosing spondylitis is associated with an increased risk of vertebral and nonvertebral clinical fractures: a population-based cohort study: as and increased risk of vertebral and nonvertebral clinical fractures, J Bone Miner Res, 29, 1770, 10.1002/jbmr.2217 Haroon, 2015, Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study, Ann Intern Med, 163, 409, 10.7326/M14-2470 Prieto-Alhambra, 2015, Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study, Osteoporos Int, 26, 85, 10.1007/s00198-014-2939-3 Kubota, 2015, Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database, BMJ Open, 5, e006450, 10.1136/bmjopen-2014-006450 Oh, 2017, Epidemiology and cardiovascular comorbidities in patients with psoriasis: a Korean nationwide population-based cohort study, J Dermatol, 44, 621, 10.1111/1346-8138.13761 Salahadeen, 2015, Nationwide population-based study of cause-specific death rates in patients with psoriasis, J Eur Acad Dermatol Venereol, 29, 1002, 10.1111/jdv.12523 Ji, 2009, Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden, Br J Cancer, 100, 1499, 10.1038/sj.bjc.6605027 Jensen, 2018, Risk of uncommon cancers in patients with psoriasis: a Danish nationwide cohort study, J Eur Acad Dermatol Venereol, 32, 601, 10.1111/jdv.14610 Khalid, 2013, Psoriasis and new-onset diabetes: a Danish nationwide cohort study, Diabetes Care, 36, 2402, 10.2337/dc12-2330 Egeberg, 2015, Increased risk of migraine in patients with psoriasis: a Danish nationwide cohort study, J Am Acad Dermatol, 73, 829, 10.1016/j.jaad.2015.08.039 Egeberg, 2016, Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study, Br J Dermatol, 175, 487, 10.1111/bjd.14528 Egeberg, 2015, Association of psoriatic disease with uveitis: a Danish nationwide cohort study, JAMA Dermatol, 151, 1200, 10.1001/jamadermatol.2015.1986 Khalid, 2014, Sarcoidosis in patients with psoriasis: a population-based cohort study, PLoS ONE, 9, e109632, 10.1371/journal.pone.0109632 Ahlehoff, 2015, Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort, J Eur Acad Dermatol Venereol, 29, 1128, 10.1111/jdv.12768 Ahlehoff, 2011, Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study, J Intern Med, 270, 147, 10.1111/j.1365-2796.2010.02310.x Khalid, 2014, Psoriasis and risk of heart failure: a nationwide cohort study, Eur J Heart Fail, 16, 743, 10.1002/ejhf.113 Khalid, 2015, Increased risk of aortic valve stenosis in patients with psoriasis: a nationwide cohort study, Eur Heart J, 36, 2177, 10.1093/eurheartj/ehv185 Egeberg, 2016, Impact of depression on risk of myocardial infarction, stroke and cardiovascular death in patients with psoriasis: a Danish nationwide study, Acta Derm Venereol, 96, 218, 10.2340/00015555-2218 Schmitt, 2009, Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample: psychiatric and cardiovascular comorbidity in psoriasis, J Eur Acad Dermatol Venereol, 24, 885, 10.1111/j.1468-3083.2009.03537.x Egeberg, 2017, Risk of myocardial infarction in patients with psoriasis and psoriatic arthritis: a nationwide cohort study, Acta Dermato Venereol, 97, 819, 10.2340/00015555-2657 Lindström, 2015, Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register, Scand J Rheumatol, 44, 369, 10.3109/03009742.2015.1010572 Löfvendahl, 2014, Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden – a population-based register study, PLoS One, 9, e98024, 10.1371/journal.pone.0098024 Quantin C, Roussot A, Cottenet J, Besson J, Fagot-Campagna A, Tala S. Étude des algorithmes de définition de pathologies dans le système national d’information inter-régime de l’assurance maladie (SNIIIRAM). https://www.ameli.fr/l-assurance-maladie/statistiques-et-publications/etudes-en-sante-publique/cartographie-des-pathologies-et-des-depenses/methodologie.php [Internet]. https://www.ameli.fr/l-assurance-maladie/statistiques-et-publications/etudes-en-sante-publique/cartographie-des-pathologies-et-des-depenses/methodologie.php. Disponible sur : https://www.ameli.fr/l-assurance-maladie/statistiques-et-publications/etudes-en-sante-publique/cartographie-des-pathologies-et-des-depenses/methodologie.php. Chapitre II : Plateforme des données de santé (Articles L. 1462-1 à L. 1462-2) – Légifrance [Internet]. [cité 21 nov 2020. Disponible sur : https://www.legifrance.gouv.fr/codes/id/LEGISCTA000038886837/2020-06-10/].